Lord, Abbett & Co. LLC Idexx Laboratories Inc Transaction History

Lord, Abbett & Co. LLC

$31.4 Billion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 07, 2024	SELL	$515.08 - $576.87 $428,546 - $479,955	-832 Reduced 7.0%	11,062 $5.97 Million
Q1 2024 May 09, 2024	SELL	$515.08 - $576.87 $428,546 - $479,955	-832 Reduced 7.0%	11,062 $5.97 Million
Q4 2023 Oct 07, 2024	SELL	$391.37 - $557.56 $36 Million - $51.3 Million	-92,071 Reduced 88.56%	11,894 $6.6 Million
Q4 2023 Feb 12, 2024	BUY	$391.37 - $557.56 $4.65 Million - $6.63 Million	11,894 New	11,894 $6.6 Million
Q2 2023 Oct 07, 2024	SELL	$450.7 - $503.61 $10.3 Million - $11.5 Million	-22,863 Reduced 18.03%	103,965 $52.2 Million
Q2 2023 Aug 14, 2023	SELL	$450.7 - $503.61 $10.3 Million - $11.5 Million	-22,863 Reduced 18.03%	103,965 $52.2 Million
Q1 2023 Oct 07, 2024	BUY	$406.01 - $514.59 $47.6 Million - $60.3 Million	117,144 Added 1209.67%	126,828 $63.4 Million
Q1 2023 May 12, 2023	BUY	$406.01 - $514.59 $47.6 Million - $60.3 Million	117,144 Added 1209.67%	126,828 $63.4 Million
Q4 2022 Oct 07, 2024	BUY	$324.64 - $441.27 $3.14 Million - $4.27 Million	9,684 New	9,684 $3.95 Million
Q4 2022 Feb 10, 2023	BUY	$324.64 - $441.27 $3.14 Million - $4.27 Million	9,684 New	9,684 $3.95 Million
Q2 2022 Aug 12, 2022	SELL	$327.37 - $553.44 $46,486 - $78,588	-142 Reduced 1.16%	12,122 $4.25 Million
Q1 2022 May 13, 2022	SELL	$466.52 - $631.01 $2.2 Million - $2.98 Million	-4,725 Reduced 27.81%	12,264 $6.71 Million
Q4 2021 Feb 11, 2022	SELL	$586.54 - $666.48 $115 Million - $130 Million	-195,328 Reduced 92.0%	16,989 $11.2 Million
Q3 2021 Nov 09, 2021	SELL	$621.9 - $705.76 $19.6 Million - $22.2 Million	-31,462 Reduced 12.91%	212,317 $132 Million
Q2 2021 Aug 11, 2021	BUY	$486.36 - $637.08 $81,222 - $106,392	167 Added 0.07%	243,779 $154 Million
Q1 2021 May 11, 2021	SELL	$465.18 - $551.79 $44.5 Million - $52.7 Million	-95,571 Reduced 28.18%	243,612 $119 Million
Q4 2020 Feb 09, 2021	BUY	$383.85 - $499.87 $56.9 Million - $74.1 Million	148,257 Added 77.65%	339,183 $170 Million
Q3 2020 Nov 12, 2020	BUY	$334.54 - $406.31 $1.2 Million - $1.45 Million	3,575 Added 1.91%	190,926 $75.1 Million
Q2 2020 Aug 14, 2020	BUY	$230.66 - $330.16 $43.2 Million - $61.9 Million	187,351 New	187,351 $61.9 Million
Q4 2019 Feb 14, 2020	SELL	$248.66 - $285.01 $15.1 Million - $17.4 Million	-60,885 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$260.07 - $289.93 $230,161 - $256,588	885 Added 1.48%	60,885 $16.6 Million
Q2 2019 Aug 14, 2019	BUY	$215.53 - $275.33 $12.9 Million - $16.5 Million	60,000 New	60,000 $16.5 Million
Q4 2018 Feb 14, 2019	SELL	$176.18 - $248.92 $38.4 Million - $54.2 Million	-217,917 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$218.82 - $254.46 $49.2 Million - $57.2 Million	-224,925 Reduced 50.79%	217,917 $54.4 Million
Q2 2018 Aug 14, 2018	BUY	$185.56 - $227.9 $13.6 Million - $16.7 Million	73,116 Added 19.78%	442,842 $96.5 Million
Q1 2018 May 15, 2018	BUY	$157.81 - $204.73 $58.3 Million - $75.7 Million	369,726 New	369,726 $70.8 Million
Q4 2017 Feb 14, 2018	SELL	$147.68 - $168.37 $16.8 Million - $19.1 Million	-113,735 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$150.32 - $166.46 $915,899 - $1.01 Million	6,093 Added 5.66%	113,735 $17.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	107,642	107,642 $17.4 Million

Others Institutions Holding IDXX

# of Institutions

1,193

Shares Held

72.6M

Call Options Held

167K

Put Options Held

343K

Vanguard Group Inc Valley Forge, PA

9.7M
Shares

$4.2 Billion
0.09% of portfolio
Black Rock Inc. New York, NY

9.6M
Shares

$4.15 Billion
0.11% of portfolio
State Street Corp Boston, MA

3.61M
Shares

$1.56 Billion
0.08% of portfolio
Alliancebernstein L.P. New York, NY

2.82M
Shares

$1.22 Billion
0.5% of portfolio
Terry Smith Fundsmith LLP | London, X0

2.66M
Shares

$1.15 Billion
5.45% of portfolio

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $36B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account